Allient Q3 2026 Revenue and Margins Hit Records as Backlog Reaches $351.5 Million

Allient Inc. (Nasdaq: ALNT) reported record fiscal third-quarter revenue and margins as higher volumes, favorable business mix and productivity initiatives drove operating leverage, while record orders and backlog strengthened the company’s visibility into early 2027.

Revenue for the quarter ended September 30, 2026, increased 18% year over year to $164.4 million. Organic revenue rose 19.1% in constant currency, with foreign exchange creating a $0.9 million headwind. Aerospace and defense, vehicle and industrial demand led the increase, while medical sales declined slightly.

Gross profit climbed to $60.2 million, and gross margin expanded 330 basis points to a record 36.6%. Allient attributed the improvement to higher volume, favorable mix, its Simplify to Accelerate NOW, or STAN, program, and the application of lean operating tools.

Operating income rose to $22.3 million from $12.2 million a year earlier. The operating margin reached a record 13.6%, up 480 basis points, as operating costs declined by 150 basis points as a percentage of revenue to 23.0%, despite spending related to growth.

GAAP net income more than doubled to $15.3 million, or $0.91 per diluted share, from $6.5 million, or $0.39 per share, in the prior-year quarter. Adjusted net income increased 82% to $18.0 million, while adjusted diluted earnings per share rose to $1.07 from $0.59.

Adjusted EBITDA advanced 46% to $29.7 million, lifting the adjusted EBITDA margin to 18.0% from 14.6%. Interest expense decreased 27% to $2.5 million because of lower average debt balances. Allient expects a full-year 2026 tax rate of approximately 21% to 23%.

Aerospace, Vehicle and Industrial Markets Lead Growth

Aerospace and defense revenue increased 36% year over year, supported by defense-related demand and program timing. Vehicle sales grew 27% on commercial automotive demand and accelerated shipments, while industrial revenue rose 15% as data center, infrastructure and industrial automation activity contributed to growth.

Medical revenue declined 2%, as stronger demand for surgical applications was offset by medical mobility performance.

Data center and infrastructure-related sales totaled $21.1 million, or 12.9% of quarterly revenue. On a trailing-12-month basis, those sales reached $63.2 million and represented 10.5% of total revenue. U.S. customers accounted for 57% of third-quarter sales.

Record Orders Expand Visibility

Orders rose 64% from a year earlier and 8% sequentially to a record $218.1 million, led by industrial and aerospace and defense demand. The quarterly book-to-bill ratio was 1.33.

Backlog increased 52% year over year and 18% from the second quarter to a record $351.5 million. Allient said it expects most of the backlog to convert to revenue within six to 12 months, providing a positive outlook through the fourth quarter and into early 2027.

Management identified data center and infrastructure, aerospace and defense, and higher-value motion, controls and power solutions as targeted growth areas. Near-term priorities include converting backlog, supporting internal growth opportunities and maintaining discipline around investment.

Cash Flow Trails Earnings Growth

Cash generation was weaker despite the improvement in earnings. Third-quarter operating cash flow declined to $2.0 million from $4.7 million a year earlier, reflecting the timing of receivables and strategic inventory purchases intended to support record demand. After $3.6 million of capital expenditures, free cash flow was negative $1.6 million, compared with positive $2.8 million in the prior-year quarter.

For the first nine months of 2026, operating cash flow totaled $22.1 million, down from $43.1 million, while free cash flow fell to $11.4 million from $38.0 million. Allient expects full-year capital spending of $12 million to $15 million. Its financial priorities are reducing inventory, strengthening working-capital management, lowering costs and paying down debt.

Total debt stood at $173.4 million at September 30, down $7.0 million from the end of 2025. Net debt decreased to $133.7 million, and the non-GAAP leverage ratio improved to 1.49 times from 1.82 times. The company reported $39.6 million in cash and cash equivalents and $162.0 million of unused revolving-credit capacity.

Allient expects fiscal 2026 restructuring costs of approximately $2 million, of which $1.5 million had been incurred through the first nine months. Third-quarter restructuring costs were $15,000, compared with $0.8 million a year earlier, reflecting lower Dothan transition costs and the timing of other STAN initiatives.

The company cautioned that its outlook remains subject to economic and industry conditions, customer and supplier performance, global supply-chain developments, the pace of bookings relative to shipments, market acceptance, competitive responses and its ability to convert backlog into sales. Working-capital requirements associated with elevated demand also remain relevant after weighing on third-quarter cash flow.